Acura Pharmaceuticals, Inc. Stock
Stocks
ACUR
US00509L8028
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | -80.00% |
|
-.--% | -80.00% |
| 06-23 | Acura Pharmaceuticals, Inc. announced that it has received $0.2 million in funding | CI |
| 05-28 | Acura Pharmaceuticals, Inc. announced that it has received $0.1 million in funding | CI |
| Market Cap | 3.28M 2.88M 2.68M 2.46M 4.62M 318M 4.7M 32.03M 12.49M 155M 12.31M 12.04M 537M | P/E 2020 |
-5.25x | P/E 2021 | -25x |
|---|---|---|---|---|---|
| Enterprise Value | 3.41M 3M 2.79M 2.57M 4.81M 331M 4.9M 33.35M 13.01M 161M 12.82M 12.54M 559M | EV / Sales 2020 |
2.91x | EV / Sales 2021 | 20.9x |
| Free-Float |
98.31% | Yield 2020 * |
-
| Yield 2021 | - |
| 1 day | -80.00% | ||
| Current month | -88.89% | ||
| 1 month | -75.00% | ||
| 3 months | -75.00% | ||
| 6 months | -80.00% | ||
| Current year | -80.00% |
| 1 week | 0 |  | 0 |
| 1 month | 0 | | 0 |
| Current year | 0 | | 0.01 |
| 1 year | 0 | | 0.01 |
| 3 years | 0 | | 0.75 |
| 5 years | 0 | | 0.75 |
| 10 years | 0 | | 1.98 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Jones
CEO | Chief Executive Officer | 67 | 2011-03-31 |
Bob Seiser
DFI | Director of Finance/CFO | 62 | 2024-07-31 |
Albert Brzeczko
CTO | Chief Tech/Sci/R&D Officer | 69 | 2009-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
William Skelly
CHM | Chairman | 75 | 1996-09-30 |
| Director/Board Member | 55 | 2002-11-30 | |
Bruce Wesson
BRD | Director/Board Member | 83 | 1998-02-28 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/2/26 | Fiscal year | Director | 150,000 | 0.2273% | ||
| 1/2/26 | Fiscal year | Director | 150,000 | 0.2273% | ||
| 1/2/26 | Fiscal year | Director | 150,000 | 0.2273% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -80.00% | -.--% | -99.00% | -75.00% | 19.99K | |
| +1.23% | +0.35% | +51.62% | +87.98% | 55.92B | |
| +3.94% | +10.16% | +67.69% | +72.98% | 56.67B | |
| +0.25% | +0.55% | -19.67% | -15.22% | 23.28B | |
| +0.72% | -0.05% | +3.84% | +409.54% | 23.28B | |
| -0.36% | +5.73% | +30.99% | -3.58% | 20.54B | |
| -0.54% | +1.55% | +26.32% | -29.55% | 17.78B | |
| -1.44% | +5.67% | +32.54% | +544.11% | 15.9B | |
| -2.54% | -8.73% | +164.11% | +289.45% | 14.64B | |
| +1.22% | -0.05% | +22.58% | +182.63% | 13.99B | |
| Average | -7.75% | +1.14% | +28.10% | +146.33% | 24.2B | |
| Weighted average by Cap. | +1.05% | +3.18% | +44.19% | +136.69% |
| 2020 | 2021 | |
|---|---|---|
| Net sales | 3.57M 3.14M 2.92M 2.68M 5.03M 346M 5.12M 34.88M 13.6M 169M 13.4M 13.11M 585M | 1.56M 1.37M 1.28M 1.17M 2.2M 151M 2.24M 15.27M 5.96M 73.83M 5.87M 5.74M 256M |
| Net income | -1.21M -1.06M -987K -908K -1.7M -117M -1.73M -11.8M -4.6M -57.06M -4.54M -4.44M -198M | -879K -773K -718K -661K -1.24M -85.12M -1.26M -8.59M -3.35M -41.52M -3.3M -3.23M -144M |
| Net Debt | 5.86M 5.15M 4.78M 4.4M 8.25M 567M 8.4M 57.21M 22.32M 277M 21.98M 21.51M 960M | 135K 119K 110K 101K 190K 13.07M 194K 1.32M 514K 6.38M 507K 496K 22.12M |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-21 | US$0.000300 | +200.00% | 720 |
- Stock Market
- Stocks
- ACUR Stock
Select your edition
All financial news and data tailored to specific country editions
